COMMUNIQUÉS West-GlobeNewswire

Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference
05/01/2026
EMERYVILLE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune [...]
Permanent J Code for ZUSDURI™ Now in Effect, Expanding Patient Access to Innovative Bladder Cancer Therapy
05/01/2026
PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today [...]
HOOPP hits 500,000-member milestone, strengthening retirement security for Ontario’s healthcare community
05/01/2026
Half a million futures. One pension promise. TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan has surpassed the 500,000-membership mark, an important milestone that reflects HOOPP’s [...]
Compass Therapeutics Announces Key Leadership Appointments
05/01/2026
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple [...]
LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ™ in the Middle East
05/01/2026
Exclusive distribution agreement includes revenue sharing in addition to upfront and milestone payments to LENZ SAN DIEGO and DUBAI, United Arab Emirates, Jan. 05, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. ( [...]
BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12
05/01/2026
SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. , a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, [...]
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
05/01/2026
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the hospital setting [...]
Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel
05/01/2026
- Expansion plans are based on requests for product access received from surgeons and hospitals in Israel - - Expansion of Symvess into other territories, including those in Europe and the Middle East, is also planned [...]
ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
05/01/2026
UNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( OTC: PRPH ) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company’s underlying asset [...]
TME Pharma provides update on its activities
05/01/2026
TME Pharma provides update on its activities Berlin, Germany , January 5, 2025, 08.00 CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel [...]
TME PHARMA FAIT LE POINT SUR SES ACTIVITÉS
05/01/2026
TME PHARMA FAIT LE POINT SUR SES ACTIVITÉS Berlin, Allemagne, 5 janvier 2025, 8 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de biotechnologie au stade clinique spécialisée dans le [...]
Nicox Announces Complete Repayment of Kreos Capital Debt and Extends Cash Runway Beyond 2027 with New Additional Financing
05/01/2026
Press Release Nicox Announces Complete Repayment of Kreos Capital Debt and Extends Cash Runway Beyond 2027 with New Additional Financing Company’s position strengthened, enabling flexibility in strategic discussions All [...]
Nicox annonce le remboursement intégral de sa dette avec Kreos Capital et étend son horizon de trésorerie au-delà de 2027 grâce à un nouveau financement complémentaire
05/01/2026
Communiqué de presse Nicox annonce le remboursement intégral de sa dette avec Kreos Capital et étend son horizon de trésorerie au-delà de 2027 grâce à un nouveau financement complémentaire La position de la Société sort [...]
Burning Rock Announces Founder’s Purchase of Its ADSs
05/01/2026
GUANGZHOU, China, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in [...]
Idorsia’s JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
05/01/2026
Idorsia receives approval from Health Canada for JERAYGO ™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension. JERAYGO is a new oral antihypertensive [...]
argenx Announces Leadership Transition Marking Next Evolution of Growth
05/01/2026
Tim Van Hauwermeiren to transition from CEO to Non-Executive Director and Chairman of Board of Directors and Karen Massey to transition from COO to CEO and Executive Director January 5, 2026 7:00 a.m. CET Amsterdam, the [...]
Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes
05/01/2026
Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes If approved, Tzield would be the first disease-modifying therapy to delay the onset of stage 3 T1D in children aged [...]
Communiqué de presse : Le médicament Tzield de Sanofi a été accepté pour un examen prioritaire aux États-Unis pour les jeunes enfants atteints de diabète de type 1 de stade 2
05/01/2026
Le médicament Tzield de Sanofi a été accepté pour un examen prioritaire aux États-Unis pour les jeunes enfants atteints de diabète de type 1 de stade 2 Si elle est approuvée, Tzield serait la première thérapie modifiant [...]
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
05/01/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase III part of the Phase [...]

Pages